Patent details

Basic Information

Publication number:

LUC00062

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP141735092

Legal Status:

Invalid

Application number:

LUC00062

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/14/969

Marketing Authorization Type:

Marketing Authorization Date:

29/12/2014

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

02/02/2018

First Marketing Authorization date:

29/12/2014

Grant date:

28/03/2018

Activation date:

Publication date:

08/02/2018

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

29/12/2029

SPC Extension Expiration:

29/12/2029

Rejection date:

Withdrawal date:

Owner

From:

02/02/2018

 

 

Name:

Clinuvel Pharmaceuticals Limited

Address:

Level 6, 15 Queen Street, Melbourne, VIC 3000, Australia (AU)

Agent

Name:

Office FREYLINGER S.A.

From:

02/02/2018

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Publication

Bulletin

1

Bulletin Heading:

SPC1

Bulletin edition number:

2018/04

Publication date:

23/03/2018

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:

SPC2

Bulletin edition number:

2018/05

Publication date:

11/04/2018

Description:

Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:

31/08/2027

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
02/02/2018	Application Form	4
08/02/2018	Outgoing Correspondence	1
02/02/2018	General Document	4
28/03/2018	Certificate	1
28/03/2018	Publication	1
02/02/2018	General Document	30
08/02/2018	Publication	1